The role of the proteins Kar9 and Myo2 in orienting the mitotic spindle of budding yeast

BACKGROUND: Two genetic 'pathways' contribute to the fidelity of nuclear segregation during the process of budding in the yeast Saccharomyces cerevisiae. An early pathway, involving Kar9p and other proteins, orients the mitotic spindle along the mother-bud axis. Upon the onset of anaphase, cytoplasmic dynein provides the motive force for nuclear movement into the bud. Loss of either pathway results in nuclear-migration defects; loss of both is lethal. Here, to visualize the functional steps leading to correct spindle orientation along the mother-bud axis, we imaged live yeast cells expressing Kar9p and dynein as green fluorescent protein fusions. RESULTS: Transport of Kar9p into the bud was found to require the myosin Myo2p. Kar9p interacted with microtubules through the microtubule-binding protein Bim1p and facilitated microtubule penetration into the bud. Once microtubules entered the bud, Kar9p provided a platform for microtubule capture at the bud cortex. Kar9p was also observed at sites of microtubule shortening in the bud, suggesting that Kar9p couples microtubule shortening to nuclear migration. CONCLUSIONS: Thus, Kar9p provides a key link between the actin cytoskeleton and microtubules early in the cell cycle. A cooperative mechanism between Kar9p and Myo2p facilitates the pre-anaphase orientation of the spindle. Later, Kar9p couples microtubule disassembly with nuclear migration.     

Phosphorylation of the (Na,K)-ATPase by a plasma membrane-bound protein kinase in friend erythroleukemia cells

A decrease in the activity of the (Na,K)-ATPase is an early and essential step in commitment of Friend virus-infected murine erythroleukemia cells to terminal erythroid differentiation. Plasma membranes from these cells were purified and shown to contain ouabain-inhibitable (Na,K)-ATPase present as approximately 0.4% of the total membrane protein. Protein kinase activity also co-purified with the plasma membrane and preferentially phosphorylated a Nonidet P-40 detergent-extractable 100,000-Da peptide. The 100,000-Da phosphopeptide migrated with the alpha subunit of dog kidney (Na,K)-ATPase when electrophoresis was carried out in the presence of sodium dodecyl sulfate in either 5 or 10% polyacrylamide gels. In two-dimensional gel electrophoresis, it separated into a series of spots between pH 5.1 and 5.4, while dog kidney alpha subunit appeared as a doublet at pH 5.3-5.4. When Nonidet P-40-solubilized plasma membranes were passed through a ouabain affinity column in the presence of Mg2+, Na+, and ATP, the 100,000-Da phosphopeptide was retained and could be eluted by ouabain. This peptide was also phosphorylated in living murine erythroleukemia cells, and proteolysis patterns of the peptide labeled in vitro, the peptide labeled in vivo, and the purified dog kidney alpha subunit using V8 protease were nearly identical. Phosphothreonine was detected in both the peptides labeled in vivo and in vitro.     

A novel endo-glucanase from the thermophilic bacterium Geobacillus sp. 70PC53 with high activity and stability over a broad range of temperatures

A thermophilic Geobacillus bacterium secreting high activity of endo-glucanase (EC 3.2.1.4) was isolated from rice straw compost supplemented with pig manure. A full-length gene of 1,104 bp, celA, encoding this glycosyl hydrolase family 5 endo-glucanase of 368 amino acids was isolated. No related gene from Geobacillus has been reported previously. The recombinant CelA expressed in Escherichia coli had an optimal activity at 65°C and pH 5.0, and it exhibited tenfold greater specific activity than the commercially available Trichoderma reesei endo-glucanase. CelA displayed activity over a broad temperature range from 45 to 75°C and was a thermostable enzyme with 90% activity retained after heating at 65°C for 6 h. Interestingly, CelA activity could be enhanced by 100% in the presence of 2 mM MnSO₄. CelA had high specific activity over β-d-glucan from barley and Lichenan, making it a potentially useful enzyme in biofuel and food industries.     

The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts

The Bordetella type III secretion system (T3SS) effector protein BteA is necessary and sufficient for rapid cytotoxicity in a wide range of mammalian cells. We show that BteA is highly conserved and functionally interchangeable between Bordetella bronchiseptica, Bordetella pertussis and Bordetella parapertussis . The identification of BteA sequences required for cytotoxicity allowed the construction of non-cytotoxic mutants for localization studies. BteA derivatives were targeted to lipid rafts and showed clear colocalization with cortical actin, ezrin and the lipid raft marker GM1. We hypothesized that BteA associates with the cytoplasmic face of lipid rafts to locally modulate host cell responses to Bordetella attachment. B. bronchiseptica adhered to host cells almost exclusively to GM1-enriched lipid raft microdomains and BteA colocalized to these same sites following T3SS-mediated translocation. Disruption of lipid rafts with methyl-β-cyclodextrin protected cells from T3SS-induced cytotoxicity. Localization to lipid rafts was mediated by a 130-amino-acid lipid raft targeting domain at the N-terminus of BteA, and homologous domains were identified in virulence factors from other bacterial species. Lipid raft targeting sequences from a T3SS effector (Plu4750) and an RTX-type toxin (Plu3217) from Photorhabdus luminescens directed fusion proteins to lipid rafts in a manner identical to the N-terminus of BteA.     

Enhanced Interferon Signaling Pathway in Oral Cancer Revealed by Quantitative Proteome Analysis of Microdissected Specimens Using 16O/18O Labeling and Integrated Two-dimensional LC-ESI-MALDI Tandem MS

Oral squamous cell carcinoma (OSCC) remains one of the most common cancers worldwide, and the mortality rate of this disease has increased in recent years. No molecular markers are available to assist with the early detection and therapeutic evaluation of OSCC; thus, identification of differentially expressed proteins may assist with the detection of potential disease markers and shed light on the molecular mechanisms of OSCC pathogenesis. We performed a multidimensional ¹⁶O/¹⁸O proteomics analysis using an integrated ESI-ion trap and MALDI-TOF/TOF MS system and a computational data analysis pipeline to identify proteins that are differentially expressed in microdissected OSCC tumor cells relative to adjacent non-tumor epithelia. We identified 1233 unique proteins in microdissected oral squamous epithelia obtained from three pairs of OSCC specimens with a false discovery rate of <3%. Among these, 977 proteins were quantified between tumor and non-tumor cells. Our data revealed 80 dysregulated proteins (53 up-regulated and 27 down-regulated) when a 2.5-fold change was used as the threshold. Immunohistochemical staining and Western blot analyses were performed to confirm the overexpression of 12 up-regulated proteins in OSCC tissues. When the biological roles of 80 differentially expressed proteins were assessed via MetaCore™ analysis, the interferon (IFN) signaling pathway emerged as one of the most significantly altered pathways in OSCC. As many as 20% (10 of 53) of the up-regulated proteins belonged to the IFN-stimulated gene (ISG) family, including ubiquitin cross-reactive protein (UCRP)/ISG15. Using head-and-neck cancer tissue microarrays, we determined that UCRP is overexpressed in the majority of cheek and tongue cancers and in several cases of larynx cancer. In addition, we found that IFN-β stimulates UCRP expression in oral cancer cells and enhances their motility in vitro. Our findings shed new light on OSCC pathogenesis and provide a basis for the future development of novel biomarkers.Oral cancer is one of the most common cancers worldwide. In Taiwan, it remains the sixth most prevalent cancer overall and the fourth most common cancer to afflict males. Over the past 2 decades, the overall incidence and morbidity rates of patients with oral cancer have increased continuously. Epidemiological studies show that ∼50–70% of patients who undergo surgery for oral cancer die within 5 years (1–6). This poor prognosis predominantly reflects late stage presentation, secondary cancer occurrence, local recurrence, and metastasis (7) as well as the lack of suitable markers for cancer detection. Therefore, there is an urgent need to identify proteins that are dysregulated in patients with oral cancer. Such proteins would serve as a valuable resource to find markers for the early diagnosis and disease monitoring of patients with oral cancer.Oral cancer, a subtype of head-and-neck squamous cell carcinoma (HNSCC),¹ can form at various locations within the oral cavity, including the lips, tongue, buccal surfaces, gingiva, palate, floor of mouth, and oropharynx. Tongue and buccal cancers are the most common and most serious types of oral squamous cell carcinoma (OSCC) especially in southeast Asia (2, 8). Alcohol abuse, smoking, and betel nut chewing are the main risk factors for OSCC. Genome-wide approaches have revealed many epigenetic and genetic alterations in patients with OSCC, including several biochemical pathways (9–11). However, these studies have provided little information regarding alterations in the protein profiles of patients with OSCC. Recently state-of-the-art proteomics technologies have revealed alterations in protein abundance, posttranslational modification and turnover, and spatial and temporal distribution within tumor specimens. Using proteomics approaches, aberrantly expressed proteins have been identified in body fluids (12–14), frozen or paraffin-embedded tissues (15–18), and cultured cell lines (19–22). The fold changes in protein expression in samples from healthy and cancerous states as well as the roles of each protein in disease progression must be determined to identify potential candidates for biomarkers and therapeutic targets.Blood samples are often used in clinical studies because they are less invasive and more convenient than other types of bodily samples and can be analyzed using automatic and high throughput techniques. Unfortunately the extremely dynamic range of protein concentrations in serum and plasma impedes the direct discovery of potential biomarkers (23, 24). Proteins can be released into the blood from diseased tissues during cell death or via secretory pathways. To counteract this problem, serum and plasma biomarkers are sometimes identified by analyzing differential protein expression in tumors and adjacent normal tissues (25).Like many other types of solid tumors, OSCCs often contain heterogeneous cell populations. Laser capture microdissection (LCM) is a common technique used to dissect a particular tumor cell type from heterogeneous cell populations, thereby reducing the tissue complexity and facilitating the discovery of tumor-associated molecules in small samples (9, 26–28). Several laboratories have studied differential protein expression in microdissected tissue specimens from patients with head-and-neck cancer in efforts to discover novel tumor markers (15, 17, 29–31). However, the semiquantitative approaches used in these studies may have limited the number of potential markers identified as well as the reliability of the protein quantification. To minimize technical variations and improve the reliability of protein quantification, a variety of sophisticated stable isotope labeling techniques have been developed for MS-based proteomics analysis, including chemical (32, 33), metabolic (34, 35), and enzymatic (36–38) labeling techniques. Improvements in the quality and accuracy of quantitative proteomics analysis via such stable isotope labeling strategies have facilitated the discovery of potential tumor markers in malignancies such as OSCC/HNSCC (16, 39, 40).Here we describe a strategy consisting of LCM, ¹⁸O labeling, two-dimensional (2D) LC separation and an integrated ESI-MS/MS and MALDI-TOF/TOF MS (ESI-MALDI tandem MS) system. This strategy was used to identify differentially expressed proteins in OSCC cells microdissected from oral cancer tissue biopsies. A computational data analysis pipeline was also developed to calculate the relative abundances of ¹⁶O- and ¹⁸O-labeled peptides (similar to that described in a previous report (26)) and to assist with multidimensional protein identification and quantification. Using three pairs of OSCC specimens, we identified 1233 unique proteins with a false discovery rate less than 3%. Of these, we quantified 977 non-redundant proteins in which 80 proteins displayed ≥2.5-fold changes in expression in microdissected tumor cells versus non-tumor cells. We validated these results in 12 selected targets via immunohistochemical staining and Western blot analysis of OSCC tissues. Our findings reveal that the interferon (IFN) signaling pathway is significantly altered in OSCC lesions.     

Function and Assembly of DNA Looping,Clustering, and Microtubule Attachment Complexes within a Eukaryotic Kinetochore

The kinetochore is a complex protein–DNA assembly that provides the mechanical linkage between microtubules and the centromere DNA of each chromosome. Centromere DNA in all eukaryotes is wrapped around a unique nucleosome that contains the histone H3 variant CENP-A (Cse4p in Saccharomyces cerevisiae). Here, we report that the inner kinetochore complex (CBF3) is required for pericentric DNA looping at the Cse4p-containing nucleosome. DNA within the pericentric loop occupies a spatially confined area that is radially displaced from the interpolar central spindle. Microtubule-binding kinetochore complexes are not involved in pericentric DNA looping but are required for the geometric organization of DNA loops around the spindle microtubules in metaphase. Thus, the mitotic segregation apparatus is a composite structure composed of kinetochore and interpolar microtubules, the kinetochore, and organized pericentric DNA loops. The linkage of microtubule-binding to centromere DNA-looping complexes positions the pericentric chromatin loops and stabilizes the dynamic properties of individual kinetochore complexes in mitosis.     

Drosophila notal bristle as a novel assessment tool for pathogenic study of Tau toxicity and screening of therapeutic compounds

To elucidate the Tau gain-of-toxicity functional mechanism and to search for potential treatments, we overexpressed human Tau variants (hTau) in the dorsal mesothorax (notum) of Drosophila. Overexpression of Tau variants caused loss of notal bristles, and the phenotype was used for evaluating toxicity of ectopic Tau. The bristle loss phenotype was found to be highly associated with the toxicity of hyperphosphoryled Tau in flies. We have shown that the bristle loss phenotype can be rescued either by reducing Glycogen synthase kinase 3β (GSK3β)/Shaggy (Sgg) activity or overexpressing Bβ2 regulatory subunits of PP2A. Elevated expression of the Drosophila Bβ2 homolog, Twins (Tws), also alleviated neuritic dystrophy of the dorsal arborization (da) neuron caused by Tau aggregation. Additionally, lowering endogenous Tau dosage was beneficial as it ameliorated the bristle loss phenotype. Finally, the bristle loss phenotype was used to evaluate the efficacy of potential therapeutic compounds. The GSK3β inhibitor, alsterpaullone, was found to suppress toxicity of Tau in a concentration-dependent manner. The notum of Drosophila, thus, provides a new tool and insights into Tau-induced toxicity. It could also potentially assist in screening new drugs for possible therapeutic intervention.